According to our findings, sepsis patients had higher levels of MPO expression in peripheral blood mononuclear cells, which is consistent with other studies (Schrijver et al., 2017), suggesting that MPO has the potential to serve as a biomarker to distinguish sepsis from infection-negative systemic inflammation. This evidence concerns the gene MPO and Sepsis.